Aax Biotech

Developer of immunotherapies for cancer and autoimmune therapies

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2020 language aaxbiotech.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace accelerating. Cited 22 times.

YearFilings
20231
20241
20261

Investor mix

4 investors on record; lead investors include KI Holding, Northislet, Phase2Phase.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon